Indian J Pharm Close
 

Figure 6: Tert-butylhydroquinone ameliorates type 2 diabetes mellitus through AMPKα2/AKT/PI3K signaling. In diabetes, Tert-butylhydroquinone induces AMPKα2 activation, which enhances phosphatidylinositol 3-kinase (PIK) and AKT phosphorylation. Meanwhile, p-AKT interacts with GLUT4 and GSK3β in hepatic cells for type 2 diabetes mellitus alleviation

Figure 6: Tert-butylhydroquinone ameliorates type 2 diabetes mellitus through AMPKα2/AKT/PI3K signaling. In diabetes, Tert-butylhydroquinone induces AMPKα2 activation, which enhances phosphatidylinositol 3-kinase (PIK) and AKT phosphorylation. Meanwhile, p-AKT interacts with GLUT4 and GSK3β in hepatic cells for type 2 diabetes mellitus alleviation